End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 EGP | -5.38% | -5.38% | -21.66% |
May. 19 | Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 36.64B 770M | Sales 2025 * | 48.93B 1.03B | Capitalization | 2.48B 52.08M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.76M | Net income 2025 * | 527M 11.07M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.65B 76.63M | Net Debt 2025 * | 3.44B 72.28M | EV / Sales 2025 * | 0.12 x |
P/E ratio 2024 * |
7.69
x | P/E ratio 2025 * |
5.02
x | Employees | 5,500 |
Yield 2024 * |
1.1% | Yield 2025 * |
1.71% | Free-Float | 61.4% |
1 day | -5.38% | ||
1 week | -5.38% | ||
Current month | -6.11% | ||
1 month | +1.65% | ||
3 months | -24.54% | ||
6 months | -28.70% | ||
Current year | -21.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-09 | 2.46 | -5.38% | 8,504,444 |
24-06-06 | 2.6 | -1.89% | 4,041,286 |
24-06-05 | 2.65 | -2.57% | 13,629,830 |
24-06-04 | 2.72 | -1.09% | 13,907,280 |
24-06-03 | 2.75 | +5.77% | 24,621,130 |
End-of-day quote Egyptian Exchange, June 08, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.66% | 52.17M | |
-39.33% | 13.67B | |
-8.96% | 7.95B | |
+4.90% | 5.86B | |
-14.12% | 5.71B | |
-3.07% | 4.6B | |
+70.58% | 4.5B | |
-8.29% | 3.77B | |
-22.05% | 3.05B | |
-12.77% | 2.81B |
- Stock Market
- Equities
- ISPH Stock